Truist Securities Maintains Buy on BKV, Lowers Price Target to $34

Benzinga Newsdesk www.benzinga.com Negative 51.0%

Neg 51% Neu 0% Pos 0%

Truist Securities analyst Gabe Daoud maintains BKV (NYSE:BKV) with a Buy and lowers the price target from $37 to $34.

Comments

No comments yet. Be the first!